Ross: Jarushka

Early data suggests this can cut the risk of recurrence in half for certain patients. In an era of "influencers" and viral health trends, Dr. Jarushka Ross represents the opposite: the quiet, rigorous, data-driven clinician who sits with a terrified family at 6 PM on a Friday.

She isn’t looking for a cure-all magic bullet. She is looking for control . She wants to turn lung cancer from a death sentence into a chronic illness—like diabetes or high blood pressure. Something you manage, not something you die from. jarushka ross

By advocating for low-dose CT screening (a test that saves more lives than mammograms or pap smears) and early biomarker testing, Ross is trying to drag lung cancer out of the dark ages and into the era of precision prevention. Currently, back in Ireland as a leading consultant, Ross is focused on the next frontier: adjuvant immunotherapy . The idea is simple but radical—don’t wait for the cancer to come back after surgery. Hit the microscopic leftovers immediately with immunotherapy while the immune system is still intact. Early data suggests this can cut the risk

Ross is ferocious on this point. In interviews and grand rounds, she repeatedly notes that up to 20% of lung cancer deaths occur in never-smokers. She points out the rise of EGFR and ALK mutations in young, non-smoking women—a cohort that is mysteriously increasing. She isn’t looking for a cure-all magic bullet

In plain English: She figured out why the cure sometimes kills you, and how to stop it.

If you know someone who has ever heard the words "you have a spot on your lung," the work being done by Jarushka Ross is the reason they might live to see next year. Jarushka Ross is proof that the biggest breakthroughs in medicine aren't always flashy. Sometimes, they are boring, essential safety manuals written by a woman who cares as much about the patient's quality of life as she does about the x-ray.